| |
| |
|
| Insider
Information: |
Rubin Paul D |
| Relationship: |
Sr. VP Clinical Dev. &... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
326,601 |
|
|
Indirect Shares
|
13,422 |
|
|
| Direct
Value |
$8,432,838 |
|
|
|
Indirect Value
|
$346,556 |
|
|
| Total
Shares |
340,023 |
|
|
| Total
Value |
$8,779,394 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
XOMA Corporation |
XOMA |
Sr. VP Clinical Dev. &... |
2016-03-22 |
326,601 |
2016-03-22 |
13,422 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2016-03-22 |
4 |
S |
$0.78 |
$18,985 |
D/D |
(24,194) |
326,601 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2016-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,141 |
350,795 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
198,330 |
338,654 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-08-14 |
4 |
D |
$0.83 |
$9,003 |
D/D |
(10,801) |
138,292 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,748 |
149,093 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-15 |
4 |
OE |
$3.04 |
$15,200 |
D/D |
5,000 |
127,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-15 |
4 |
AS |
$4.60 |
$22,992 |
D/D |
(5,000) |
122,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-10 |
4 |
OE |
$3.04 |
$88,160 |
D/D |
29,000 |
151,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-10 |
4 |
AS |
$4.55 |
$131,985 |
D/D |
(29,000) |
122,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-09 |
4 |
AS |
$4.55 |
$20,020 |
D/D |
(4,400) |
122,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-07-09 |
4 |
OE |
$3.04 |
$13,376 |
D/D |
4,400 |
126,745 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-05-28 |
4 |
S |
$3.60 |
$6,437 |
D/D |
(1,788) |
122,345 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,666 |
124,133 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-03-23 |
4 |
AS |
$3.94 |
$128,879 |
D/D |
(32,742) |
119,467 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,346 |
172,744 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-03-18 |
4 |
D |
$4.01 |
$82,356 |
D/D |
(20,535) |
152,209 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
64,900 |
142,398 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-31 |
5 |
A |
$3.83 |
$6,019 |
I/I |
1,571 |
6,881 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-31 |
5 |
A |
$3.41 |
$2,057 |
D/D |
603 |
77,498 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-15 |
4 |
OE |
$3.04 |
$4,864 |
D/D |
1,600 |
73,621 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-15 |
4 |
AS |
$4.63 |
$7,401 |
D/D |
(1,600) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-11-20 |
4 |
AS |
$4.55 |
$22,750 |
D/D |
(5,000) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-11-20 |
4 |
OE |
$3.04 |
$15,200 |
D/D |
5,000 |
77,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-10-28 |
4 |
OE |
$3.04 |
$15,200 |
D/D |
5,000 |
77,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-10-28 |
4 |
AS |
$4.57 |
$22,829 |
D/D |
(5,000) |
72,021 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
